Qube Research & Technologies Ltd

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1729829 LONDON, X0

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$19,196,151

+$16,648,844 QoQ

Shares Held

196,924

+548.8% QoQ

Ownership

0.352%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#58

of 269 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. DNTH ranks #30 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,196,151	196,924	+548.8%	Shares	Sole	2026-08-14
2026-03-31	$2,547,307	30,354	+194.9%	Shares	Sole	2026-05-15
2025-12-31	$424,215	10,294	+32.8%	Shares	Sole	2026-02-17
2024-09-30	$212,277	7,753	-30.8%	Shares	Sole	2024-11-14
2024-06-30	$289,985	11,205	-83.5%	Shares	Sole	2024-08-14
2024-03-31	$2,035,380	67,846	+8359.6%	Shares	Sole	2024-05-14
2023-12-31	$8,340	802	+26633.3%	Shares	Sole	2024-02-13
2023-09-30	$41	3	—	Shares	Sole	2023-11-13
2022-09-30 MGTA	—	20,414	-9.2%	Shares	Sole	2022-11-14
2022-06-30 MGTA	—	22,480	+71.8%	Shares	Sole	2022-08-15
2021-06-30 MGTA	—	13,082	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.